Mia's Feed
Medical News & Research

Preventable Cancers Leading to Higher Mortality Among People with Disabilities, New Study Finds

Preventable Cancers Leading to Higher Mortality Among People with Disabilities, New Study Finds

Share this article

A new study reveals that people with disabilities are dying from preventable cancers at higher rates due to barriers in screening and healthcare access. Addressing systemic inequities is essential to improve outcomes and ensure equitable cancer care.

2 min read

People with disabilities face significant disparities in cancer outcomes, with many missing out on early detection and screening programs that could save their lives. Recent research indicates that this group is more likely to be diagnosed at an advanced stage and has lower survival rates compared to those without disabilities. The study, which analyzed 73 studies from around the world, highlights how systemic barriers and accessibility issues limit access to vital cancer screening for individuals with disabilities, including screenings for breast, cervical, and bowel cancers. Consequently, they are at a higher risk of dying from preventable cancers.

The evidence suggests that delays in diagnosis and inadequate treatment contribute to poorer outcomes for people with disabilities. For instance, a UK study revealed more than a third of cancer cases in individuals with intellectual disabilities were diagnosed only after emergency visits, often at an advanced stage. Similar findings from global reviews show that people with disabilities frequently receive lower-quality care, experience treatment delays, and face obstacles in accessing hospital services and pain management.

In Australia, cancer has emerged as a leading cause of early death among people with disabilities, accounting for about 20% of excess deaths in this population. Factors such as living in disadvantaged circumstances, lifestyle behaviors like smoking and high alcohol consumption, and barriers within healthcare systems contribute to these disparities. Challenges include inaccessible healthcare facilities, communication barriers, discriminatory attitudes, and lack of support for informed consent.

Addressing these inequities requires a comprehensive approach. Recommendations include designing prevention programs that are inclusive, improving accessibility of screening facilities, ensuring that healthcare providers receive training on the needs of people with disabilities, and actively involving individuals with disabilities in making decisions about their care. By implementing these strategies, we can work toward equitable cancer care and improve outcomes for one of society’s most vulnerable populations.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Florida Ends All Vaccine Mandates as West Coast States Establish Independent Guidelines

Florida plans to eliminate all vaccine mandates, while West Coast states establish their own immunization guidelines amid ongoing debates over public health policies and individual freedoms.

Repositioning Rheumatoid Arthritis Medication to Combat COVID-19-Induced Inflammation

A promising study reveals that iguratimod, a drug used for rheumatoid arthritis, may help reduce excessive inflammation in COVID-19 patients without compromising immune response. This could lead to safer therapies for managing severe COVID-19 complications.

Potential Risks of Psilocybin During the Postpartum Period

Emerging research indicates that psilocybin may pose significant risks during the postpartum period, potentially worsening depression and affecting offspring development. UC Davis's latest study highlights the importance of cautious use and further investigation into psychedelic safety for new mothers.

New Advanced Tool Offers More Accurate Prediction of Cardiovascular Disease Risk

A new risk prediction model by the American Heart Association offers more accurate and equitable assessment of cardiovascular disease risk across diverse populations, enhancing preventive healthcare strategies.